Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
---|
02/15/2001 | WO2001010406A2 Facilitating the preservation of sight by increasing optic nerve, choroidal and retinal blood flow |
02/15/2001 | WO2001010392A2 Composition for restoring defects in calcified tissues |
02/15/2001 | WO2001010365A1 Patient temperature regulation method and apparatus |
02/15/2001 | WO2000057721A3 Edible solids for treatment of glucose metabolism disorders |
02/15/2001 | CA2380312A1 Formulations for parenteral use of estramustine phosphate and albumin |
02/15/2001 | CA2378401A1 Implantable active ingredient depot |
02/15/2001 | CA2378257A1 Method for increasing optic nerve, choroidal and retinal blood flow to facilitate the preservation of sight |
02/14/2001 | EP1075489A2 Water-soluble pro-drugs of 2,6-diisopropylphenol analogues |
02/14/2001 | EP1075268A1 Use of a fluoride ion vector for preparing a medicine for preventing or treating diseases associated with helicobacter pylori |
02/14/2001 | EP1075267A2 Treatment of celiac disease |
02/14/2001 | CN1283996A Method/thiol biochdes |
02/14/2001 | CN1283994A Methods for treatment of neuro-and nephro-disorders and therapeutic toxicities using aminothiol compounds |
02/14/2001 | CN1283466A Powdered medicine 'Kouqiangyanhousan' and its preparing process |
02/14/2001 | CN1061889C Pile eliminating powder |
02/14/2001 | CN1061883C Medicine for removing thrombus and promoting blood circulation |
02/14/2001 | CN1061871C Wind-expelling and pain-alleviating drug for external use |
02/14/2001 | CN1061870C Medicated wine for sauna bath |
02/14/2001 | CN1061860C External-use medicine for treating urethritis |
02/14/2001 | CN1061845C External-use ointment for eczema |
02/13/2001 | US6187817 Preventing or reducing ototoxicity in a human, cat or dog by administering d-methionine free of the l-isomer |
02/13/2001 | US6187810 Administering to improve the therapeutic effect and the bioavailability of known medicaments; administering to diminish acute or chronic toxicity of a natural alkaloid, cardiac glycoside or synthetic drug |
02/13/2001 | US6187347 Coagulation of blood from wounds |
02/13/2001 | US6187346 Intrauterine chemical cauterizing method and composition |
02/13/2001 | US6187334 Low methoxyl pectin, sodium alginates and acids, carrageenan and gellan gum |
02/13/2001 | US6187317 Natural anti-diarrheal composition and method |
02/13/2001 | CA2190753C Anti-acne compositions |
02/12/2001 | CA2314915A1 Peroxovanadium compounds as protein tyrosine phosphate (ptp) inhibitors: their inhibitory effects on angiogenesis, restenosis and the production of endothelins, and their stimulating effects on the immune response |
02/12/2001 | CA2280249A1 Vanadium compounds as anti-angiogenics and as inhibitors of endothelin production |
02/08/2001 | WO2001009616A2 Method for determining physiological effects of hemoglobin |
02/08/2001 | WO2001009558A1 Methods and apparatus for producing phase change ice particulate saline slurries |
02/08/2001 | WO2001009149A1 Bisplatinum complexes active through the oral route |
02/08/2001 | WO2001009000A1 A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids |
02/08/2001 | WO2001008693A2 Combination therapy using pentafluorobenzenesulfonamide and platin compound |
02/08/2001 | WO2001008692A1 Xenon an nmda antagonist |
02/08/2001 | WO2001008593A2 Method for inducing hypothermia |
02/08/2001 | WO2001008496A1 Antiparasitic formulation |
02/08/2001 | WO2000067769A8 Enhanced survival of cancer patients treated with erythropoietin and antitumor agents |
02/08/2001 | WO2000057729A3 Beverages for treatment of glucose metabolism disorders |
02/08/2001 | CA2393917A1 Bisplatinum complexes active through the oral route |
02/07/2001 | EP1074261A1 Iodophor compositions for preventing mastitis |
02/07/2001 | EP1073436A1 IMPROVED METHOD FOR ERADICATION OF $i(HELICOBACTER PYLORI) |
02/07/2001 | EP1073416A1 Use of inhaled no as anti-inflammatory agent |
02/07/2001 | EP0649310B1 Stable, anticorrosive peracetic/peroxide sterilant |
02/07/2001 | CN1282614A Combined magnetic picking for treating angioma |
02/07/2001 | CN1282592A Plaster for treating bone diseases |
02/07/2001 | CN1061558C Ginkgo and calcium capsule |
02/07/2001 | CN1061554C Chinese patent drug for treating hepatitis B |
02/07/2001 | CN1061553C Ointment for toothache and stomatocase |
02/07/2001 | CN1061552C Epilepsy recovering pill and preparing process thereof |
02/07/2001 | CN1061545C Chinese medicine ointment for burn and its scar |
02/06/2001 | US6184363 Inhibitors of β-lactamases and uses therefor |
02/06/2001 | US6183785 Source of zinc, preferably zinc gluconate, and chlorhexidine. |
02/06/2001 | US6183776 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate |
02/06/2001 | CA2217768C Flavorful zinc compositions for oral use incorporating copper |
02/01/2001 | WO2001007082A1 Combination of an anti-ep-cam antibody with a chemotherapeutic agent |
02/01/2001 | WO2001007073A1 Novel use of hypo-osmotic saline solutions and medicine based on said solutions |
02/01/2001 | WO2001007065A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
02/01/2001 | WO2001007058A2 Parenteral cisplatin emulsion |
02/01/2001 | WO2001006985A2 Select amino acids as zinc-solubilizing agents in anti-viral genital formulations |
02/01/2001 | WO2000038717A3 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
02/01/2001 | WO2000037107A3 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
02/01/2001 | WO1999066951A8 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
02/01/2001 | CA2379824A1 Novel use of hypo-osmotic saline solutions and medicine based on said solutions |
02/01/2001 | CA2379815A1 Parenteral cisplatin emulsion |
01/31/2001 | EP1072604A1 Calcium complex of (4R)-4-bis(carboxy-kappa.O)methyl amino-.kappa.N-6,9-bis (carboxy-.kappa.O)methyl-1-(4,4-diphenylcyclohexyl)oxy-1-hydroxy-2-oxa-6,9-diaza-1-phosphaundecan- 11-yl acid-.kappa.N6,.kappa.N9,.kappa.O11 1-oxidato(6-)-,hexahydrogen, corresponding salts, pharmaceutical composition containing such complex, its therapeutic use and its use as additive as diagnostic agent as well as a process for preparing the complex |
01/31/2001 | EP1072253A1 Oral compositions |
01/31/2001 | EP1072198A1 Preparation especially for use as medicament and/or nutritional supplement |
01/31/2001 | EP1071481A1 Preparation for regenerating collagen |
01/31/2001 | EP1071435A2 Silicate-containing powders providing controlled, sustained gas release |
01/31/2001 | EP1071398A1 Implants for administering substances and methods of producing implants |
01/31/2001 | CN1282218A Compositions and method for treatment of primary and metastatic neoplastic diseases using arsenic compounds |
01/31/2001 | CN1281708A Medicine for curing stomatocace and its preparation method |
01/31/2001 | CN1281705A Yugan pill for curing hepatitis and ascites due to cirrhosis |
01/31/2001 | CN1061253C Medicine for curing bone disease |
01/31/2001 | CN1061236C Ointment for curing eczema |
01/31/2001 | CN1061232C Medical composition for curing gastritis and ulcer |
01/31/2001 | CN1061231C Preparing method for cataract eye drops and cataract eye drops prepared by said method |
01/30/2001 | US6180764 Process for producing hydrotalcites by hydrolyzing metal alcoholates |
01/30/2001 | US6180113 Used in tumor therapy and interventional radiology |
01/30/2001 | US6180094 Remedies for hyperphosphatemia |
01/25/2001 | WO2001005797A1 Titanium derived compounds, preparation and use thereof |
01/25/2001 | WO2001005731A1 Method for immobilising physiologically active compounds |
01/25/2001 | WO2001005411A1 Compositions addressing inflammation and/or degenerative disorders |
01/25/2001 | WO2001005409A1 Novel spinal and epidural anaesthetic |
01/25/2001 | WO2001005372A2 A liposome composition having resistance to freeze/thaw damage |
01/25/2001 | WO2001005356A2 Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant |
01/25/2001 | WO2001005250A1 Potassium calcium citrate compositions and methods for production |
01/25/2001 | WO2001005233A1 Disinfecting composition based on h2o2, acids and metal ions |
01/25/2001 | WO2000066183A8 Vascular embolic materials having multifunctions |
01/25/2001 | WO2000066093A3 Combined preparations comprising morpholine anthracyclines and anticancer agent |
01/25/2001 | DE19933705A1 New anaesthetic for epidural administration comprises liposomes containing a lipophilic gas, especially xenon |
01/25/2001 | DE19933704A1 Use of liquid preparations containing lipophilic gases such as xenon for neuroprotection or neuroregeneration e.g. in cases of cerebral hypoxia and ischemia |
01/25/2001 | CA2379366A1 A liposome composition having resistance to freeze/thaw damage |
01/25/2001 | CA2371328A1 Disinfecting composition based on h2o2, acids and metal ions |
01/24/2001 | EP1070502A2 Compositions and methods for treating or preventing inflammatory diseases |
01/24/2001 | EP1069918A1 Enhancement of cellular gallium uptake |
01/24/2001 | EP0859813A4 Bioactive composite material for repair of hard and soft tissues |
01/24/2001 | EP0662830B1 (pi)-BOND AROMATIC VITAMIN CHELATES |
01/24/2001 | EP0557498B1 Bone-growth-stimulating composition |
01/24/2001 | CN1281366A Prevention and treatment of amyloidogenic disease |